PLUS1
Best deals to access real time data! |
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
CHART Trader
Monthly Subscription
for only
|
|
Big Cap Pro
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Aridis Pharmaceuticals Inc | ARDS | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.2186 | 2.95% | 7.624 | 7.6771 | 7.58 | 7.60 | 7.4054 | 10:00:56 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 7.61 | 7.76 | 0.15 | 1.93% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 12 | 2,707 | $ 7.62 | $ 20,617 | 29,475 | 4.07 - 12.40 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 09:57:22 | 500 | $ 7.624 | USD |
Aridis Pharmaceuticals Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 67.95M | 8.91M | $ -22.11M | 1.99 | 1.80 | 7.47M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | 16.20% |
Aridis Pharmaceuticals News
| Date | Time | Source | News Article |
|---|---|---|---|
| 1/02/2020 | 05:30 | PR Newswire (US) | Aridis Pharmaceuticals Appoints Michael A. Nazak as Chief.. |
| 11/13/2019 | 16:05 | PR Newswire (US) | Aridis Pharmaceuticals Announces Third Quarter 2019 Results |
| 10/11/2019 | 16:16 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 10/11/2019 | 05:30 | PR Newswire (US) | Aridis Pharmaceuticals Appoints Infectious Disease Expert.. |
| 10/03/2019 | 06:03 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 9/30/2019 | 05:30 | PR Newswire (US) | Aridis Pharmaceuticals Executes License Agreement with The.. |
| 9/27/2019 | 10:41 | Edgar (US Regulatory) | Current Report Filing (8-k) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ARDS Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 6.84 | 8.29 | 6.60 | 7.38 | 13,195 | 0.784 | 11.46% |
| 1 Month | 4.35 | 8.49 | 4.18 | 5.62 | 45,211 | 3.27 | 75.26% |
| 3 Months | 5.74 | 8.49 | 4.07 | 5.47 | 18,202 | 1.88 | 32.82% |
| 6 Months | 10.00 | 12.40 | 4.07 | 6.93 | 13,610 | -2.38 | -23.76% |
| 1 Year | 9.09 | 12.40 | 4.07 | 7.56 | 8,917 | -1.47 | -16.13% |
| 3 Years | 13.02 | 13.85 | 4.07 | 9.56 | 10,663 | -5.40 | -41.44% |
| 5 Years | 13.02 | 13.85 | 4.07 | 9.56 | 10,663 | -5.40 | -41.44% |
Aridis Pharmaceuticals Description
| Aridis Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is engaged in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections. |
